SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-14-457143
Filing Date
2014-12-30
Accepted
2014-12-30 16:37:07
Documents
4
Period of Report
2014-12-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A d842508d8ka.htm 8-K/A 22724
2 EX-10.1 d842508dex101.htm EX-10.1 88463
3 EX-10.2 d842508dex102.htm EX-10.2 88383
4 GRAPHIC g842508g04p16.jpg GRAPHIC 4867
  Complete submission text file 0001193125-14-457143.txt   207861
Mailing Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020
Business Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

IRS No.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 000-22873 | Film No.: 141316380
SIC: 2835 In Vitro & In Vivo Diagnostic Substances